RxDoctor Payments Data

Heidi Blanton, APRN

Family · Springfield, OHNPI 1740940527

Payments from drug & device makers

$203in general payments, 2019–2025

Across 12 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$66
  • Lilly USA, LLC$31
  • Seqirus USA Inc$19
  • Biohaven Pharmaceutical Holding Company Ltd.$17
  • AbbVie$15
  • Pfizer$15
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$203100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$203 in reported general payments places this provider in the 40th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$34,976
Medicare patients
159
Services billed
866

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide48$77,002
MounjaroTirzepatide43$69,081
JardianceEmpagliflozin61$68,495
TrulicityDulaglutide41$59,800
OzempicSemaglutide41$54,544
FarxigaDapagliflozin Propanediol58$48,840
EliquisApixaban36$34,915
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$31,251
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr44$27,129
JanuviaSitagliptin Phosphate19$23,877
XareltoRivaroxaban20$21,794
Bevespi AerosphereGlycopyrrolate/Formoterol Fum26$13,558
MyrbetriqMirabegron12$10,793
Breo ElliptaFluticasone/Vilanterol21$9,390
Spiriva RespimatTiotropium Bromide11$8,396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$31$128,88184 claims
PfizerEliquis$15$34,91536 claims
MerckJanuvia$12$23,87719 claims
Johnson & JohnsonXarelto$13$21,79420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 6,812 family providers in Ohio.

Other family in Springfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →